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Abstract
Background: Pneumonia is the leading infectious cause of death among children, with approximately half of deaths
attributable to pneumonia occurring in limited health resource settings of sub-Saharan Africa. Clinical guidance tools
and checklists have been used to improve health outcomes and standardize care. This study was conducted to
evaluate the impact of a clinical guidance tool designed to improve outcomes for children hospitalized with severe
pneumonia in Zambia.
Methods: This study was conducted at University Teaching Hospital in Lusaka, Zambia from October 10, 2011 to March
21, 2014 among children 1 month to 5 years of age with severe pneumonia. In March 2013, a clinical guidance tool was
implemented to standardize and improve care. In-hospital mortality pre-and post-implementation was compared.
Results: Four hundred forty-three children were enrolled in the pre-intervention period and 250 in the post-intervention
period. Overall, 18.2 % of children died during hospitalization, with 44 % of deaths occurring within the first 24 h after
admission. Mortality was associated with HIV infection status, pneumonia severity, and weight-for-height z-score. Despite
improving and standardizing the care received, the clinical guidance tool did not significantly reduce mortality (relative
risk: 0.89; 95 % CI: 0.65, 1.23). The tool appeared to be more effective among HIV-exposed but uninfected children and
children younger than 6 months of age.
Conclusions: Simple tools are needed to ensure that children hospitalized with pneumonia receive the best possible
care in accordance with recommended guidelines. The clinical guidance tool was well-accepted and easy to use and
succeeded in standardizing and improving care. Further research is needed to determine if similar interventions can
improve treatment outcomes and should be implemented on a larger scale.
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Background
Pneumonia is the leading infectious cause of death in
children and was estimated to cause 15 % of the 6.3 mil-
lion deaths globally in children younger than 5 years of
age in 2013 [1]. Approximately half of deaths attribut-
able to pneumonia occur in sub-Saharan Africa [1],
where resources in the health sector are limited. Sub-
Saharan Africa is also the region most affected by
human immunodeficiency virus (HIV) infection and is
home to over 90 % of the 2.6 million children infected
with HIV globally [2]. HIV-infected children are at in-
creased risk of severe pneumonia and poor outcomes,
including death [3–6]. Increasing evidence suggests that
HIV-exposed but uninfected children may also be at in-
creased risk and this group is increasing as successful
programs to prevent mother-to-children transmission of
HIV expand [5, 7].
Guidelines on the management of children hospital-
ized with severe pneumonia provide recommendations
for diagnosis, treatment and supportive care [8]. In
* Correspondence: csutcli1@jhu.edu
1Department of Epidemiology, Bloomberg School of Public Health, Johns
Hopkins University, 615 North Wolfe Street, Baltimore, MD, USA
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sutcliffe et al. BMC Pediatrics  (2016) 16:136 
DOI 10.1186/s12887-016-0665-z
addition to antibiotic therapy, children should receive
oxygen therapy if oxygen saturation is less than 90 % as
well as supportive care, including removal of secretions,
treatment for fever or wheeze, and receipt of mainten-
ance fluids and nutritional support. HIV-exposed infants
should receive cotrimoxazole for presumptive pneumo-
cystis pneumonia [9]. Addressing these needs requires
not only adequate supplies of antibiotics, oxygen, bron-
chodilators and appropriate equipment, but frequent
monitoring by nurses and physicians to identify and ad-
dress each child’s medical needs. In resource-limited set-
tings, many of these elements may be challenging to
deliver. Determining the need for oxygen can be difficult
given the absence or limited availability of pulse oxi-
meters in health facilities. When oxygen is needed,
shortages are common, and when available the equip-
ment required for administration and monitoring may
not be present or functional [10]. Critical shortages of
healthcare workers are also common throughout the re-
gion, with only 2.3 health workers estimated to be avail-
able per 1000 population [11]. Consequently, many
children with pneumonia may not receive the recom-
mended standard of care and may experience poorer
outcomes.
Clinical guidance tools and checklists have been used
in critical care, anesthesia and surgical settings with
demonstrated improvement in patient safety and out-
comes [12–15], as well as increased adherence to pub-
lished guidelines leading to standardized patient care
[16]. This study was conducted to evaluate the impact of
a clinical guidance tool designed to improve outcomes




This study was conducted at the University Teaching
Hospital (UTH) in Lusaka, Zambia within a sample of
children enrolled into the Pneumonia Etiology Research
for Child Health (PERCH) study [17]. Zambia is catego-
rized as a lower middle income country with 60.5 % of
the population living below the poverty level [18]. In
2013, the maternal and under-5 mortality rates were es-
timated to be 398 per 100,000 live births and 75 per
1000 live births, respectively [19]. Immunization cover-
age with the third dose of diphtheria-pertussis-tetanus
was estimated to be 79 % [18]. Haemophilus influenzae
type b and pneumococcal conjugate vaccines were intro-
duced into the national immunization program in 2004
and 2013, respectively [20]. In 2013, the prevalence of
HIV among adults was estimated to be 13.3 % in Zambia
and 16.3 % in Lusaka [19].
UTH is a 1500-bed academic center and tertiary care
facility with 447 pediatric beds. UTH serves as a referral
hospital for approximately 1.3 million people living
within the greater Lusaka District. The Department of
Paediatrics and Child Health operates a 24-h outpatient
(OPD) and in-patient clinical care service with labora-
tory, radiological and nutritional support care services.
The Department of Paediatrics and Child Health con-
sists of an admission ward, 3 general pediatric wards, a
malnutrition ward, pediatric haemato-oncology wards,
an isolation infectious disease ward, a pediatric intensive
care unit and a neonatal intensive care unit. All children
are first evaluated in the OPD. Severely ill children, in-
cluding the majority of children with pneumonia, are
triaged to the emergency room for resuscitation and
stabilization, including administration of intravenous
fluids for correction of shock or dehydration, oxygen
therapy and empirical antibiotic therapy. Basic diagnos-
tic investigations such as complete blood counts, bio-
chemistry tests (liver and renal function tests, blood
sugar, etc.), microbiology procedures (gram stains, spu-
tum for acid fast bacilli and blood cultures) and chest ra-
diographs are commonly performed, when available, on
children admitted with pneumonia. Since 2005, routine
opt out HIV testing for every admitted child has been
performed [21].
PERCH Study
This study was nested within the PERCH study site in
Zambia. The design and methods of the PERCH study
were described elsewhere [17, 22, 23]. Briefly, PERCH is
a multi-center, case–control study to determine the eti-
ology of pneumonia among children younger than
5 years of age living in developing countries. All children
admitted to UTH between the ages of 28 days and
59 months with severe or very severe pneumonia,
consistent with the World Health Organization defini-
tions when the study began [24], and living within a pre-
defined area of Lusaka were eligible for enrollment.
Children were excluded from the study if they were hos-
pitalized in the 14 days prior to admission or if they had
previously been enrolled 30 days prior to admission.
Written informed consent for participation was obtained
from parents or guardians. The PERCH study was con-
ducted from October 2011 to March 2014.
Suspected cases of severe or very severe pneumonia
presenting to UTH were assessed for eligibility using a
pre-screening assessment tool. Upon enrollment into the
PERCH study, an extensive demographic and clinical
history was obtained from the caregiver and the child
underwent a clinical assessment, including chest radiog-
raphy. Specimens collected included induced sputum,
blood, pleural fluid (if appropriate), nasal and throat
swabs, and urine. At 24 and 48 h following admission,
all children underwent a limited clinical assessment, in-
cluding measurement of respiratory rate, and oxygen
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saturation, and evaluation for the presence of wheeze
and lower chest wall indrawing. At hospital discharge,
oxygen saturation, respiratory status and wheeze were
assessed and the discharge diagnosis and clinical status
of the child were recorded. Aside from these study as-
sessments, clinical care was provided by UTH nursing
and physician clinical ward staff, neither of which were
part of the PERCH study team.
HIV testing of children was initially performed upon
admission by hospital staff according to the opt-out HIV
testing protocol. In February 2012, the PERCH protocol
was changed to include rapid HIV testing (Abbott Deter-
mine®, Abbott Park, IL) of both children and consenting
mothers at enrollment. Children who tested positive
underwent confirmatory testing according to national
guidelines (HIV DNA-PCR testing for children younger
than 18 months of age and detection of plasma anti-
bodies by enzyme immunoassay [Organon Tecknika,
Boxtel, The Netherlands] for children 18 months of age
and older). Children of HIV-infected mothers were given
cotrimoxazole according to national guidelines.
Study procedures
In 2012, investigators observed that the PERCH site in
Zambia had a higher case-fatality ratio among partici-
pants than other sites and hypothesized that this may be
in part due to a lack of standardization in clinical care.
To standardize and improve the care of study children
provided by the ward staff, a clinical guidance tool was
developed in collaboration with the clinical care team
from the Department of Paediatrics and Child Health.
The tool was based on the WHO recommendations for
the management of acute respiratory illness at a referral
health facility and included best practices specific to HIV-
infected and exposed children (Table 1; Additional file 1).
To standardize antibiotic regimens provided to children
with pneumonia, 4 preferred regimens were listed. To en-
sure that HIV exposure and infection status were ap-
propriately ascertained and managed, prompts were
provided to the clinical ward staff to obtain and follow-
up on results for HIV testing as well as referral and ad-
ministration of cotrimoxazole. Prompts to the ward
staff to assess respiratory rate, temperature and oxygen
saturation were included every 6 hours to ensure the
child was appropriately monitored. Additional prompts
were provided to assess the nutritional status of the
child with referral for nutritional supplements as neces-
sary. With approval by the Department of Paediatrics
and Child Health, the clinical guidance tool was imple-
mented on March 4, 2013 for study participants. Clin-
ical decisions regarding management and treatment
were made by the ward clinical staff but the tool was
available at the child’s bedside.
Study nurses were employed on both day and night
shifts and were responsible for completing the tool
based on information in the child’s medical chart. Study
staff assessed treatment failure at 24 and 48 h after ad-
mission and the clinical status of the child upon dis-
charge. Study staff collected data on adherence to the
assessments described in the tool. Study nurses ensured
that medications and fluids were administered as pre-
scribed, oxygen therapy continued when appropriate,
and vital signs measured as recommended. In addition,
they assisted ward staff in suctioning the airways of
study participants. Ward nurses and physicians were
alerted to deviations from the tool within hours of deter-
mination so remedies could be enacted. During the
intervention period, oxygen was more readily available
at the hospital as well as certain antibiotics (e.g. intra-
venous cotrimoxazole).
This study was approved by the Boston University,
Johns Hopkins Bloomberg School of Public Health, and
Zambian ERES Converge Institutional Review Boards.
Statistical analysis
All children enrolled in the PERCH study were included
in this analysis, which consisted of a pre-post study de-
sign comparing clinical outcomes, including duration of
hospital stay and mortality, before and after implementa-
tion of the clinical guidance tool. Children enrolled from
October 10, 2011 to March 3, 2013 were included in the
pre-intervention group and children enrolled from
March 4, 2013 to March 21, 2014 were included in the
Table 1 Components of the clinical guidance tool
On admission - Antibiotics administered (4 regimens recommended)
- Assessment of HIV-exposure with recommendations
for HIV testing and cotrimoxazole prophylaxis
- Assessment of nutritional status with documentation
of feeding method implemented
- Documentation of assessments performed, including
blood culture, complete blood count and chest x-ray
- Assessment of oxygen status with recommendations
for supplemental oxygen
- Assessment of the need for supportive care (shock,
fever, wheezing, nasal secretions, maintenance fluids)
with recommendations provided
At 48 h - Assessment of criteria for treatment failure with
recommendations for switching antibiotic regimens
Ongoing care Assessment every 6 hours of:
- Room air saturation
- Chest indrawing
- Respiratory rate
Discharge - Assessment of criteria for discharge
- Documentation of oral regimen prescribed
- Documentation of discharge instructions provided
to the caregiver
- Assessment of HIV-exposure status with
recommendations for follow-up
- Assessment of nutritional status with recommendations
for follow-up
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post-intervention group. HIV infection status was de-
fined based on maternal history, HIV antibody testing
and HIV DNA testing. Children were classified as HIV
infected if they had previous documentation of HIV in-
fection, were currently receiving antiretroviral therapy or
if they had a positive HIV (as per protocol and based on
age) test performed as part of the study. Children were
classified as exposed to HIV if they were infected with
HIV, if they were HIV seropositive, if the mother was
documented to have had a positive HIV test during
pregnancy, if the mother was reported to be HIV sero-
positive during pregnancy (in the absence of a negative
serological test if <7 months of age), or if the mother
tested positive at enrollment and the child was younger
than 7 months of age. Children older than 7 months of
age with a negative reported maternal history who were
HIV seronegative were presumed to be HIV-unexposed.
Based on exposure and infection data, HIV status was
categorized as HIV-unexposed and uninfected, HIV-
exposed but uninfected, and HIV-exposed and infected.
Nine children were uninfected with unknown exposure
status and classified as HIV-unexposed and uninfected.
Four children were HIV-exposed with unknown infection
status and were classified as HIV-exposed but uninfected.
Weight-for-age (WAZ) and weight-for-height (WHZ) z-
scores were calculated based on the WHO growth stan-
dards to assess malnutrition and wasting, respectively
[25]. High pneumonia season was defined as enrollment
in January, February, March, November and December of
any given year based on historical increases in admissions
for respiratory infections [unpublished data].
Differences in demographic and clinical characteristics
between the pre- and post-intervention groups were
assessed using chi-square tests for categorical variables
and Wilcoxon rank sum tests for continuous variables.
Poisson regression with robust variance estimation was
used to compare the risk of in-hospital mortality in the
pre- and post-intervention periods. Characteristics found
to differ significantly (p < 0.05) between groups were in-
cluded in the model. As some children were missing
information on WHZ at enrollment, an indicator for
‘missing’ was used for WHZ to include all children in
the models. Interactions with pneumonia severity, HIV
infection status, age, WHZ and season were explored.
Sensitivity analyses were conducted restricting the study
population to children remaining in care for more than
24 h as they were hypothesized to receive the most clinical
benefits from the tool, and to children enrolled in the
study over the same calendar period in the pre- (March
2012-March 2013) and post-intervention (March 2013-
March 2014) groups, with no significant difference in the
results. In addition, multiple imputation methods were
explored to address missing data with no significant differ-
ence in the results.
Results
Between October 10, 2011 and March 21, 2014, 693
children were enrolled in the PERCH study, 443 in the
pre-intervention period and 250 in the post-intervention
period. Approximately half the children were male and
younger than 6 months of age at enrollment, with no
difference by intervention period (Table 2). Children en-
rolled in the post-intervention period were significantly
more likely than those enrolled in the pre-intervention
period to be admitted with very severe pneumonia
(38.4 % vs. 28.7 %; p = 0.009), to be HIV-infected (19.2 %
vs. 14.2 %; p = 0.02), to have a normal WHZ (70.4 % vs.
46.9 % with WHZ −2 to 2; p < 0.0001), and to have a
normal chest x-ray (40.9 % vs. 30.1 %; p = 0.02).
The median duration of hospitalization did not differ
between children enrolled pre- (median: 6; IQR: 4–9;
range: 1–50) and post-intervention (median: 5; IQR: 3–
9; range: 1–39; p = 0.24). Overall, 18.2 % of children died
during hospitalization (Fig. 1) with 44 % of deaths occur-
ring within the first 24 h after admission (41 % pre- and
50 % post-intervention; p = 0.34). Mortality among HIV-
exposed but uninfected children (21.1 %) and HIV-
infected children (33.3 %) was significantly higher than
among HIV-unexposed and uninfected children (12.2 %;
p < 0.0001; Fig. 1). No significant difference in mortality
was observed by intervention (relative risk [RR]: 1.01;
95 % confidence interval [CI]: 0.73, 1.41; Table 3). After
adjusting for pneumonia severity, HIV infection status,
WHZ and pneumonia season, a small but non-significant
decrease in mortality in the post-intervention period was
observed (RR: 0.89; 95 % CI: 0.65, 1.23).
Differences in the effect of the intervention on in-
hospital mortality were observed by HIV infection status
and age, with the majority of the effect observed among
HIV-exposed but uninfected children (RR: 0.48; 95 % CI:
0.22, 1.04) and children younger than 6 months of age
(RR: 0.64; 95 % CI: 0.40, 1.02) (Table 4). No differences
were observed by pneumonia severity, season or WHZ.
To evaluate potential mechanisms mediating the ef-
fect, processes impacted by the clinical tool were evalu-
ated. Four standard antibiotic regimens were promoted
during the intervention but the proportion of children
receiving other regimens did not significantly differ be-
tween the pre- and post-intervention periods (8.8 % vs.
12.1 %; p = 0.17). Increased monitoring of supportive
care was promoted and the proportion of children with
oxygen saturation ≤92 % receiving oxygen on admission
(83.3 % vs. 93.8 %; p = 0.02) and at 48 h follow-up
(76.4 % vs. 95.3 %; p = 0.001) increased significantly from
the pre- to the post-intervention period. Management of
HIV-exposed children was also promoted and a non-
significant increase in the proportion of HIV-infected
children receiving cotrimoxazole at admission or during
follow-up was observed from the pre- to the post-
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Table 2 Characteristics of children hospitalized with pneumonia at the University Teaching Hospital in Lusaka, Zambia
Characteristics at study enrollment Pre-intervention group (N = 443) Post-intervention group (N = 250) p-value
Age (months) 0.31
0–5 240 (54.2) 124 (49.6)
6–11 101 (22.8) 64 (25.6)
12–23 59 (13.3) 43 (17.2)
24–59 43 (9.7) 19 (7.6)
Male sex 234 (52.8) 133 (53.2) 0.92
Hib conjugate vaccine status 0.25
Received ≥1 dose 332 (81.0) 192 (84.6)
Received 0 doses 78 (19.0) 35 (15.4)
Missing 33 23
Pneumococcal conjugate vaccine status <0.0001
Received ≥1 dose 0 37 (18.1)
Received 0 doses 0 168 (81.9)
Missing 0 45
HIV infection status 0.02
Unexposed/uninfected 273 (61.6) 162 (64.8)
Exposed/uninfected 107 (24.1) 40 (16.0)
Infected 63 (14.2) 48 (19.2)
Weight for age z-score 0.35
≤ − 3 74 (16.7) 32 (12.8)
− 3 to −2 80 (18.1) 44 (17.6)
> − 2 288 (65.0) 174 (69.6)
Missing 1 0
Weight for height z-score <0.0001
≤ − 3 51 (12.2) 14 (5.8)
− 3 to − 2 46 (11.0) 22 (9.2)
− 2 to 2 196 (46.9) 169 (70.4)
> = 2 125 (29.9) 35 (14.6)
Missing 25 10
Mother’s education 0.7
None 20 (4.6) 10 (4.0)
Primary 170 (39.0) 105 (42.2)
Secondary or more 246 (56.4) 134 (53.8)
Missing 7 1
Very severe pneumonia 127 (28.7) 96 (38.4) 0.009
Oxygen saturation ≤92 % 191 (43.3) 113 (45.2) 0.63
Chest x-ray result 0.02
Primary endpoint pneumoniaa 79 (20.5) 49 (22.3)
Other infiltrates 67 (17.4) 24 (10.9)
Primary endpoint pneumoniaa & other infiltrates 44 (11.4) 26 (11.8)
Normal 117 (30.4) 90 (40.9)
Uninterpretable 78 (20.3) 31 (14.1)
Missing 58 30
Admitted in high pneumonia season 192 (43.3) 96 (38.4) 0.21
aImages as showing alveolar consolidation or pleural effusion
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Fig. 1 Mortality among children hospitalized with pneumonia in Zambia, by intervention and HIV infection status. Note: bars around estimates
represent 95 % confidence intervals
Table 3 Risk factors for in-hospital mortality among children hospitalized with severe pneumonia in Zambia
N In-hospital mortality (%) Crude relative risk (95 % CI) Adjusted relative risk (95 % CI)
Group
Pre-intervention 443 18.1 1 1
Post-intervention 250 18.4 1.01 (0.73, 1.41) 0.89 (0.65, 1.23)
Age (months)
0–5 364 18.7 1
6–11 165 20.0 1.07 (0.74, 1.55)
12–23 102 17.7 0.94 (0.59, 1.51)
24–59 62 11.3 0.60 (0.29, 1.25)
Pneumonia severity
Severe 470 11.5 1 1
Very severe 223 32.3 2.81 (2.05, 3.85) 2.79 (2.04, 3.82)
HIV infection status
Unexposed/uninfected 435 12.2 1 1
Exposed/uninfected 147 21.1 1.73 (1.16, 2.59) 1.73 (1.17, 2.56)
Infected 111 37.8 3.11 (2.19, 4.39) 2.86 (2.01, 4.08)
Weight for height z-score
≤ −3 65 32.3 2.23 (1.45, 3.42) 1.85 (1.19, 2.86)
− 3 to − 2 68 25.0 1.72 (1.06, 2.79) 1.57 (0.97, 2.55)
− 2 to 2 365 14.5 1 1
> =2 160 13.8 0.95 (0.60, 1.50) 1.00 (0.65, 1.55)
Pneumonia season
Low 405 21.7 1 1
High 288 13.2 0.61 (0.43, 0.86) 0.85 (0.59, 1.21)
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intervention period (85.7 % vs. 95.8 %; p = 0.08). Similar
increases were not observed among HIV-exposed but
uninfected children (68.3 % vs. 67.4 %; p = 0.91).
Adherence to the tool was assessed in terms of com-
pleteness of the forms. Sixty-seven percent of items were
completed at least 90 % of the time, with item complete-
ness ranging from 67 to 100 %. Lower completeness was
observed for items documenting management of a test
result or measure (e.g. documenting administration of
paracetamol if fever was recorded).
Discussion
In this study of children hospitalized with severe and
very severe pneumonia, 18.2 % of children died while
in hospital and almost half within the first 24 h of
admission. Mortality was associated with HIV expos-
ure and infection, pneumonia severity, and severe
malnutrition. Use of a clinical guidance tool improved
the care children received and was associated with a
small but non-significant decrease in overall in-
hospital mortality.
The prevalence of HIV infection among hospitalized
children with severe or very severe pneumonia in sub-
Saharan Africa ranged from 45-65 % in prior studies,
with a case fatality ratio of 20-34 %, 3 to 6-fold higher
than among HIV-uninfected children [3, 4, 6, 7]. While
the prevalence of HIV infection in this study was only
16 %, HIV-infected children were almost 3 times more
likely to die in hospital than HIV-uninfected children.
Similar to other studies [5], in-hospital mortality among
HIV-exposed but uninfected children was lower than
among HIV-infected children but almost two-fold
higher than among HIV-uninfected children. Reasons
for the increased risk of mortality among HIV-exposed
but uninfected children are multifactorial and could
include lower levels of maternally-acquired antibodies
to respiratory pathogens, suboptimal breastfeeding,
undernutrition, parental death, increased exposure to
infectious pathogens from HIV-infected adults, and
potential immunological abnormalities [26, 27].
The clinical guidance tool used in this study was de-
veloped to improve outcomes through standardization
of care, with particular focus on identification and man-
agement of HIV exposure and infection and provision
of supportive care. Similar to other studies [16, 28], im-
plementation of the tool improved provision of recom-
mended care for children exposed and infected with
HIV as well as children with severe pneumonia. HIV-
infected children were more likely to receive cotrimox-
azole and children in need were more likely to receive
oxygen. Despite recommending a limited set of antibi-
otics, there was no impact on the range of regimens
prescribed in the post-intervention period. This may
have been due to the limited availability of certain
Table 4 Differences in the effect of the intervention on mortality by age and HIV infection status
N pre/post intervention
period
In hospital mortality in the






< 6 months 240/124 20.8/14.5 0.64 (0.40, 1.02) 0.05
≥ 6 months 203/126 14.8/22.2 1.23 (0.79, 1.92) ref
HIV infection statusb
Unexposed/uninfected 273/162 11.4/13.6 1.20 (0.73, 1.99) ref
Exposed/uninfected 107/40 24.3/12.5 0.48 (0.22, 1.04) 0.05
Infected 63/48 36.5/39.6 0.82 (0.51, 1.33) 0.28
Pneumonia severityc
Severe 316/154 11.7/11.0 0.97 (0.57, 1.64) ref
Very severe 127/96 33.9/30.2 0.85 (0.58, 1.24) 0.68
Pneumonia seasond
Low 251/154 21.9/21.4 0.83 (0.57, 1.20) ref
High 192/96 13.0/13.5 1.08 (0.60, 1.93) 0.45
Weight-for-age z-scoree
< −2 97/36 28.9/27.8 0.58 (0.31, 1.10) 0.21
≥ −2 321/204 14.3/14.2 0.93 (0.63, 1.37) ref
amodel was adjusted for weight-for-age z-score, severity of pneumonia, HIV status, and pneumonia season
bmodel was adjusted for age, weight-for-age z-score, severity of pneumonia, and pneumonia season
cmodel was adjusted for weight-for-age z-score, HIV status, and pneumonia season
dmodel was adjusted for weight-for-age z-score, HIV status, and severity of pneumonia
emodel was adjusted for age, HIV status, severity of pneumonia, and pneumonia season
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antibiotics at the pharmacy or resistance by physicians
in changing their prescribing habits. In discussions with
study staff, nurses believed the clinical guidance tool
improved the care children received through closer and
more consistent monitoring and more rapid identifica-
tion and correction of problems and abnormalities.
They felt that the tool was simple and easy to use, as
demonstrated by the high observed adherence, and that
it was well accepted by the clinical ward staff and care-
givers. They all felt, however, that it would be difficult
to continue using the clinical guidance tool beyond the
study given the shortage of ward staff and inconsistent
availability of resources at the hospital.
Despite improvements and standardization of care,
only a small impact on overall in-hospital mortality
was observed. This may have been due in part to the
critical condition of the children at the time of
hospitalization, as almost half of the deaths occurred
within the first 24 h of admission. By the time these
children reached the hospital, death may not have
been preventable regardless of the care received. De-
lays in bringing a child with severe pneumonia to the
hospital may result from delayed recognition of symp-
toms by the mother or delays due to the health sys-
tem. Children are usually seen first at a health center
and referred to the hospital by a healthcare worker.
The health center is generally busy and children may
not be seen for several hours. In addition, ambulance
services may be slow or absent and further delay ar-
rival at the hospital. Efforts to educate new mothers
on the signs and symptoms of pneumonia and to im-
prove the referral system may improve care seeking
behaviors and ultimately outcomes [29].
The clinical guidance tool appeared to have the
greatest impact among children younger than 6 months
of age and HIV-exposed but uninfected children. Rea-
sons for this are unclear, but these children may be
most likely to achieve better outcomes with improved
supportive care, nutritional support and prompt identi-
fication and management of HIV exposure. This study
was not designed or powered to evaluate the effect of
the intervention among subgroups and further research
is needed to confirm these findings. As the largest
number of pneumonia cases and deaths were among
children younger than 6 months of age and the number
of HIV-exposed children will continue to increase, sim-
ple, clinical tools to improve pneumonia outcomes
would be useful.
There has been an increased interest in the imple-
mentation of best clinical practices, clinical guidance
tools and checklist approaches for clinical care or pa-
tient harm reduction in a wide variety of healthcare
settings, including low and middle income countries.
Programs such as the WHO’s Safe Surgery Saves
Lives [30] and Safe Childbirth Checklist [31] have
been primarily developed for and implemented in low
and middle income settings where the burden of dis-
ease is greatest, the perceived need for standardized
evidence-based clinical guidelines to improve outcomes
the strongest, and barriers to introducing costly interven-
tions involving large numbers of healthcare providers the
greatest. These efforts have been met with mixed results
[32–34], including the results found in our current study.
While there is great hope that simply introducing stan-
dardized evidence-based guidelines or checklists in any
healthcare setting will lead to better quality of care and
improved outcomes, in reality changing healthcare pro-
vider and institutional behavior, and sustaining these
changes over time, is much more difficult [35, 36]. Under-
standing cultural and institutional barriers to change, rec-
ognizing the intricate psychology for changing human
behavior, realizing the impact of politics on workplace en-
vironments, providing timely feedback to providers and
monitoring efforts, and choosing appropriate and simpli-
fied interventions in the right setting for the targeted pa-
tient population all likely impact the adoption of
standardized approaches and their success.
This study had several limitations. First, this study
was nested within the PERCH study and was conceived
and implemented in the middle of the study. Conse-
quently, the sample size was limited and the study was
not powered to detect small decreases in mortality. Sec-
ond, as the tool was partly implemented by study staff,
results may reflect implementation of the tool under
enhanced conditions. Third, the study compared 2 pe-
riods of time pre and post-intervention. In addition to
implementing the tool, other improvements were made,
including increasing coverage of study staff. Improve-
ments in mortality or outcomes may not be attributable
solely to the clinical guidance tool. Lastly, children en-
rolled in the pre and post-intervention periods differed
on several characteristics related to mortality. While
adjustments were made in the statistical analysis, it is
possible that unmeasured confounders remained.
Conclusions
At a large, urban hospital in Lusaka, Zambia, mortality
among children hospitalized with severe and very se-
vere pneumonia was high. Simple tools are needed to
ensure that these children receive the best possible care
in accordance with recommended guidelines. The clin-
ical guidance tool developed and evaluated in this study
was well-accepted and easy to use and succeeded in
standardizing and improving care. Further research is
needed to determine if similar interventions can
improve outcomes and should be implemented on a
larger scale.
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